Vasopressin in Heart Failure-Reference-Cited by-同舟云学术

Vasopressin in Heart Failure

Published:2018-08-28 Issue:5 Volume:18 Page:458-465
ISSN:1871-5303
Container-title:Endocrine, Metabolic & Immune Disorders - Drug Targets
language:en
Short-container-title:EMIDDT

Author:

Iovino Michele¹,Iacoviello Massimo²,De Pergola Giovanni³,Licchelli Brunella¹,Iovino Emanuela¹,Guastamacchia Edoardo¹,Giagulli Vito A.¹,Triggiani Vincenzo¹

Affiliation:

1. Interdisciplinary Department of Medicine-Section of Internal Medicine, Geriatrics, Endocrinology and Rare Diseases. University of Bari "Aldo Moro", School of Medicine, Policlinico, Piazza Giulio Cesare 11, 70124 Bari, Italy

2. Cardiology Unit, Cardiothoracic Department, Policlinic University Hospital, Bari, Italy

3. 3Clinical Nutrition Unit, Medical Oncology, Department of Internal Medicine and Clinical Oncology, University of Bari, School of Medicine, Policlinico, Piazza Giulio Cesare 11, 70124 Bari, Italy

Publisher

Bentham Science Publishers Ltd.

Subject

Immunology and Allergy,Endocrinology, Diabetes and Metabolism

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypertension and Heart Failure: From Pathophysiology to Treatment;International Journal of Molecular Sciences;2024-06-17

2. Neuromodulation of Cardiac Ischemic Pain: Role of the Autonomic Nervous System and Vasopressin;Journal of Integrative Neuroscience;2024-03-01

3. Arginine vasopressin induces ferroptosis to promote heart failure via activation of the V1aR/CaN/NFATC3 pathway;Acta Biochimica et Biophysica Sinica;2024-01-01

4. Neurohumoral Activation in Heart Failure;International Journal of Molecular Sciences;2023-10-23

5. Right Ventricular Dysfunction and Exercise Impairment in Patients with Heart Failure, Insulin Resistance, and Diabetes Mellitus: Insights from the T.O.S.CA. Registry (Cardiovascular Diabetology 2022);Endocrine, Metabolic & Immune Disorders - Drug Targets;2023-08